Clinical Trial: Tirofiban Reducing periprocedural stroke onset of IntraCranial Artery angioplaSTy: a multicenter, double-blinded, randomized, and placebo-controlled trial (China)

China, Aug. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Tirofiban Reducing periprocedural stroke onset of IntraCranial Artery angioplaSTy: a multicenter, double-blinded, randomized, and placebo-controlled trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129658

Registration Time: 2026/08/07

Type: Interventional study

Primary Sponsor: Wuxi people’s Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337151

Published by HT Digital Content Services with permission from Health Daily Digest....